Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1.
D019380:Anti-HIV Agents / Q000191:economics; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics*; D015658:HIV Infections; D006634:Histamine H1 Antagonists / Q000191:economics; D006801:Humans; D017336:Loratadine / Q000191:economics; D010330:Patents as Topic; D014481:United States
D019380:Anti-HIV Agents; D016568:Drugs, Generic; D006634:Histamine H1 Antagonists; D017336:Loratadine